Related Experiment Video

Updated: Jul 6, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Antithymocyte globulin and cyclosporin in children with acquired aplastic anemia

Jagdish Chandra1, Rahul Naithani, Rakesh Ravi

  • 1Kalawati Saran Childrens Hospital, New Delhi, India. jchandra55@ yahoo.co.in

Indian Journal of Pediatrics
|April 1, 2008
PubMed

Insights

Antithymocyte globulin (ATG) and cyclosporin combination therapy shows effectiveness in treating aplastic anemia. This treatment offers a viable option for patients ineligible for bone marrow transplantation.

Area of Science:

  • Hematology
  • Immunosuppression
  • Bone Marrow Failure Syndromes

Background:

  • Aplastic anemia is a rare but serious condition characterized by bone marrow failure.
  • Treatment options for aplastic anemia include bone marrow transplantation and immunosuppressive therapy.

Purpose of the Study:

  • To evaluate the efficacy of a combination therapy using antithymocyte globulin (ATG) and cyclosporin in pediatric patients with aplastic anemia.
  • To assess treatment response rates in patients with severe aplastic anemia (SAA) and very severe aplastic anemia (VSAA).

Main Methods:

  • A cohort of 23 pediatric patients (11 SAA, 12 VSAA) diagnosed with aplastic anemia received ATG and cyclosporin.
  • Patient responses were assessed at 6 months and 1 year post-treatment initiation.

Main Results:

  • Overall response rates at 1 year were 45% (2 complete responses, 7 partial responses).
  • Response rates were higher in SAA patients (54.5%) compared to VSAA patients (33%).
  • 55% of patients survived without achieving a response; one patient developed acute myeloid leukemia (AML).

Conclusions:

  • The combination of ATG and cyclosporin is an effective treatment for pediatric aplastic anemia.
  • This therapeutic approach is particularly beneficial for patients who are not candidates for bone marrow transplantation.
Abstract

More Related Videos

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...